# Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

> **NCT00651469** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 534 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00651469
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2004-07
- **Target enrollment:** 534 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651469, "Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00651469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*